Rheumatology

Critically ill patients with systemic lupus erythematosus show reduced ICU survival, driven largely by renal dysfunction, with glucocorticoids potentially mitigating mortality risk.

Real-world data show switching to IL-17 inhibitors after TNF inhibitor failure improves treatment retention compared with TNF cycling in psoriatic arthritis.

A new review highlights kefir-derived peptides, probiotics and kefiran as promising natural strategies for bone health and osteoporosis prevention.

Rheumatologist Rieke Alten discusses how treat-to-target care and TNF inhibition with etanercept reshape RA outcomes, with safety…

BSR has published an updated guideline on the safe use of csDMARDs, introducing new evidence, paediatric guidance, and risk-adaptive monitoring across the full life course.

Cardiac involvement was found in 35% of patients with EGPA, with pericarditis, myocarditis, and coronary vasospasms driving worse disease activity and prognosis.

New study finds early use of secukinumab in psoriatic arthritis offers no significant advantage over standard step-up treatment after one year.

Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are two prototypic forms of immune-mediated inflammatory diseases (IMID)…